ID   CX-03
AC   CVCL_RQ40
SY   Cx-03
DR   DSMZ; ACC-816
DR   DSMZCellDive; ACC-816
DR   Wikidata; Q54817058
RX   PubMed=30411161;
CC   Population: Caucasian.
CC   Characteristics: Established after xenotransplantation in SCID-mice of primary tumor cells.
CC   Doubling time: 48-72 hours (PubMed=30411161); ~4-7 days (DSMZ=ACC-816).
CC   Derived from site: In situ; Uterus; UBERON=UBERON_0000995.
ST   Source(s): DSMZ=ACC-816; PubMed=30411161
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D18S51: 12,15
ST   D19S433: 14
ST   D21S11: 29
ST   D2S1338: 17
ST   D3S1358: 15
ST   D5S818: 9,10
ST   D7S820: 10,11
ST   D8S1179: 13,14
ST   DXS101: 23
ST   FGA: 23,24
ST   Penta D: 9
ST   Penta E: 10
ST   TH01: 9.3
ST   TPOX: 8,11
ST   vWA: 14,16
DI   NCIt; C42700; Uterine carcinosarcoma
DI   ORDO; Orphanet_213610; Carcinosarcoma of the corpus uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   49Y
CA   Cancer cell line
DT   Created: 05-03-18; Last updated: 02-05-24; Version: 8
//
RX   PubMed=30411161; DOI=10.1007/s11095-018-2533-z;
RA   Bucker, Roland
RA   Schaefer, Christof
RA   Gruber, Achim Dieter
RA   Hoppe, Judith
RA   Lazzerini, Lea
RA   Barinoff, Jana
RA   Sehouli, Jalid
RA   Cichon, Gunter
RT   "Establishment of a mucin secreting cell line Cx-03 from an uterine
RT   carcino sarcoma.";
RL   Pharm. Res. 36:7.1-7.9(2018).
//